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Introduction
Children and adolescents with systemic lupus erythema-
tosis (SLE) are at risk for osteopenia and osteoporosis.
Sex hormones protect against bone loss and as SLE
itself and the immunosuppressive drugs given might
interfere with normal puberty, this could add to the risk
of bone loss among these patients.
Objectives
To evaluate the frequency of osteoporosis and hypogo-
nadism among adolescents with SLE and how far the
two conditions co-exist. The effect of disease character-
istics and immunosuppressive drugs on both conditions
are studied as well.
Methods
Thirty-six adolescents with SLE were evaluated to deter-
mine the characteristics of the disease. SLE disease activ-
ity index (SLEDAI) was used to assess SLE status. Beside
routine laboratory investigations of SLE, measurement of
follicle stimulating hormone(FSH), leutinizing hormone
(LH) and estrogen (E2) for females or testosterone for
males before and 4 hours after LH releasing hormone
analogue (0.1 ml) injection. Dual emission X-ray absorp-
tiometery (DEXA) scan was done for all patients.
Results
Eighteen (50%) patients had low bone mass density
(BMD), of these patients, 11 (31%) had osteoporosis
(BMD < -2 Z-score) and 7(19%) had osteopenia (BMD
<-1 and >-2 Z-score). Fifteen (42%) patients had hypogo-
nadism: 12 (33%) had secondary hypogonadism and 3
(9%) had primary hypogonadism. The frequency of
hypogonadism was comparable among patients with
osteopenia/osteoporosis and those with normal BMD (p
> 0.05). The age of the studied patients with osteopenia/
osteoporosis had significant negative correlation with Z-
score of DEXA scan (p < 0.05). Longer duration of SLE
was associated with higher frequency of osteopenia/
osteoporosis as well as hypogonadism among the studied
patients (p = 0.01). While patients with osteopenia/
osteoporosis had significantly higher SLEDAI as com-
pared to those with normal BMD (p = 0.01), SLEDAI
was comparable among patients with hypogonadism and
those with normal gonadal function (p > 0.05). A signifi-
cant negative correlation was found between the cumula-
tive dose of steroids and Z-score of DEXA scan among
patients with osteopenia and osteoporosis (p = 0.01).
Patients with hypogonadism had received comparable
cumulative doses of steroids and cyclophosphamide to
those with normal gonadal function (p > 0.05).
Conclusion
Osteopenia/osteoporosis and hypogonadism are common
co-morbid conditions among adolescents with SLE. Lupus
flare and steroids seem to affect BMD rather than gonadal
function. Whether hypogonadism adversely affect BMD,
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